Send feedback

HPD p.Ser54fs

c.158dup · rs895823217 · VCV642856

Pathogenic Single submitter
Classification
Pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00167%, amr)
Conditions
2
tyrosinemia type III

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 4 of 14
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP -2.9GERP -4.2
Overall
CADD29.9PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00167% Admixed American · 1/59,992 alleles
Filtering AF 0.000183% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00012%
Overall 0.000558% 9/1,613,980 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0032% 31,244
Admixed Americangrpmax 0.00167% 59,992
European (non-Finnish) 0.000508% 196,660

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
HPD
Protein
p.Ser54fs
Coding
c.158dup
MANE Select
NM_002150
dbSNP
rs895823217
Type
Duplication
Location
chr12:121857367 (GRCh38)
Gene constraint
LOEUF 0.845 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 96.00 · 4 PDB
Residue 54
the voc 1 domain
Full HPD gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

tyrosinemia type III — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hawkinsinuria

For Tyrosinemia type 3 (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hpd-p-ser54fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown